Literature DB >> 23299091

Perioperative care in gynecologic oncology.

Christina L Kushnir1, Teresa P Díaz-Montes.   

Abstract

PURPOSE OF REVIEW: To review perioperative care in gynecologic oncology with special emphasis on areas of controversy. RECENT
FINDINGS: Major gynecologic surgery still represents the cornerstone of management among women diagnosed with gynecologic malignancies. The implementation of clinical guidelines can significantly impact perioperative morbidity and mortality. Preoperative evaluation and preparation allows the surgeon to identify patient risks and develop risk factor modification strategies decreasing delays in preparation and cost and improving patient safety. Preoperative areas of controversy include preoperative testing and evaluation, use of mechanical bowel preparation, prophylactic antibiotics, and use of anticoagulants, and the timing of postoperative feeding.
SUMMARY: In healthy women undergoing gynecologic cancer surgery preoperative evaluation requirements will be minimal. For women with extensive comorbid conditions a more detailed evaluation will be required to decrease perioperative morbidity and mortality. Mechanical bowel preparations should not be required preoperatively. Preoperative administration of antibiotics and anticoagulants should be provided to all patients undergoing major gynecologic cancer surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23299091     DOI: 10.1097/GCO.0b013e32835b80f5

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  2 in total

Review 1.  Controversies in preoperative bowel preparation in gynecologic and gynecologic oncology surgery: a review of the literature.

Authors:  Michail Diakosavvas; Nikolaos Thomakos; Dimitrios Haidopoulos; Michael Liontos; Alexandros Rodolakis
Journal:  Arch Gynecol Obstet       Date:  2020-08-01       Impact factor: 2.344

2.  Which patients on a gynecologic oncology service will require perioperative transfusion? A single-center retrospective cohort study.

Authors:  Gregory W Kirschen; Samantha M Dayton; Sophia Blakey-Cheung; Michael L Pearl
Journal:  Clin Exp Obstet Gynecol       Date:  2021-02-15       Impact factor: 0.146

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.